Bicycle Therapeutics PLC
(STU:50BA)
€
3.58
+0.18 (+5.29%)
Market Cap: 250.56 Mil
Enterprise Value: -179.42 Mil
PE Ratio: 0
PB Ratio: 0.57
GF Score: 56/100 Bicycle Therapeutics PLC at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023 / 02:10PM GMT
Release Date Price:
€19.6
(+3.16%)
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
(technical difficulty) Morgan Stanley Global Healthcare conference, I'm Jeff Hung, one of the biotech analysts. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. For this session, we have Bicycle Therapeutics with CEO, Kevin Lee; Chief Development Officer, Santiago Arroyo; Head of Commercial, Jennifer Perry. Welcome.
Kevin Lee
Bicycle Therapeutics plc - Director
Thanks. Good to be here.
Questions & Answers
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
So for those who may not be familiar with Bicycle, can you provide a brief introduction?
Kevin Lee
Bicycle Therapeutics plc - Director
Sure. Bicycle is a company that works on a
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot